326,59 €
Advances in the Preclinical Study of Ischemic Stroke
Advances in the Preclinical Study of Ischemic Stroke
326,59 €
  • Išsiųsime per 14–16 d.d.
This book reports innovations in the preclinical study of stroke, including - novel tools and findings in animal models of stroke, - novel biochemical mechanisms through which ischemic damage may be both generated and limited, - novel pathways to neuroprotection. Although hypothermia has been so far the sole "neuroprotection" treatment that has survived the translation from preclinical to clinical studies, progress in both preclinical studies and in the design of clinical trials will hopefully…
326.59
  • Leidėjas:
  • Metai: 2012
  • Puslapiai: 548
  • ISBN-10: 9535102907
  • ISBN-13: 9789535102908
  • Formatas: 17 x 24.4 x 3 cm, kieti viršeliai
  • Kalba: Anglų

Advances in the Preclinical Study of Ischemic Stroke + nemokamas atvežimas! | knygos.lt

Atsiliepimai

Aprašymas

This book reports innovations in the preclinical study of stroke, including - novel tools and findings in animal models of stroke, - novel biochemical mechanisms through which ischemic damage may be both generated and limited, - novel pathways to neuroprotection. Although hypothermia has been so far the sole "neuroprotection" treatment that has survived the translation from preclinical to clinical studies, progress in both preclinical studies and in the design of clinical trials will hopefully provide more and better treatments for ischemic stroke. This book aims at providing the preclinical scientist with innovative knowledge and tools to investigate novel mechanisms of, and treatments for, ischemic brain damage.
326,59 €
Išsiųsime per 14–16 d.d.
Prisijunkite ir už šią prekę
gausite 3,27 Knygų Eurų!?

This book reports innovations in the preclinical study of stroke, including - novel tools and findings in animal models of stroke, - novel biochemical mechanisms through which ischemic damage may be both generated and limited, - novel pathways to neuroprotection. Although hypothermia has been so far the sole "neuroprotection" treatment that has survived the translation from preclinical to clinical studies, progress in both preclinical studies and in the design of clinical trials will hopefully provide more and better treatments for ischemic stroke. This book aims at providing the preclinical scientist with innovative knowledge and tools to investigate novel mechanisms of, and treatments for, ischemic brain damage.

Atsiliepimai

  • Atsiliepimų nėra
0 pirkėjai įvertino šią prekę.
5
0%
4
0%
3
0%
2
0%
1
0%